microdosing glp 1 dr tyna SHE MD Podcast Interview with Dr. Tyna Moore,
Description
Pang, B
This dose should be maintained for at least four weeks to assess tolerance and initial therapeutic response before considering further dose escalation
Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, et al
Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer s disease - protocol for a controlled, randomized double-blinded trial
The DAPA-HF, EMPEROR-REDUCED, EMPEROR-Preserved, DELIVER and other trials mentioned above consistently demonstrate the efficacy of SGLT-2i in patients with HF, regardless of LVEF or the presence of diabetes
That said, individuals who meet specific criteria (see below) may have it approved
